ProfileGDS4718 / 225242_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 45% 73% 93% 58% 71% 46% 45% 70% 85% 73% 66% 62% 46% 51% 46% 70% 85% 62% 44% 54% 80% 85% 70% 82% 67% 53% 77% 45% 69% 40% 41% 72% 67% 44% 79% 67% 53% 95% 63% 98% 71% 40% 87% 63% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.2711445
GSM549102patient 115, normal, homogenized [OPG study]7.0445273
GSM549104patient 119, normal, homogenized [OPG study]9.9139293
GSM549108patient 138, normal, homogenized [OPG study]5.9914158
GSM549119patient 077, normal, homogenized [OPG study]6.883871
GSM549133patient 032, cancer, homogenized [OPG study]5.2338346
GSM549139patient 042, cancer, homogenized [OPG study]5.2367345
GSM549099patient 107, normal, homogenized [OPG study]6.8041470
GSM549109patient 139, normal, homogenized [OPG study]8.440285
GSM549110patient 046, normal, homogenized [OPG study]7.1461673
GSM549114patient 063, normal, homogenized [OPG study]6.56566
GSM549122patient 082, normal, homogenized [OPG study]6.2816662
GSM549134patient 033, cancer, homogenized [OPG study]5.2751146
GSM549136patient 036, cancer, homogenized [OPG study]5.5085751
GSM549140patient 044, cancer, homogenized [OPG study]5.2384246
GSM549111patient 047, normal, homogenized [OPG study]6.8853970
GSM549113patient 057, normal, homogenized [OPG study]8.5824285
GSM549132patient 031, cancer, homogenized [OPG study]6.2505662
GSM549137patient 038, cancer, homogenized [OPG study]5.1729244
GSM549142patient 047, cancer, homogenized [OPG study]5.8552454
GSM549100patient 110, normal, homogenized [OPG study]7.7577580
GSM549107patient 135, normal, homogenized [OPG study]8.5409985
GSM549115patient 068, normal, homogenized [OPG study]6.8792870
GSM549116patient 072, normal, homogenized [OPG study]8.1439882
GSM549120patient 078, normal, homogenized [OPG study]6.6297367
GSM549131patient 030, cancer, homogenized [OPG study]5.6230653
GSM549118patient 074, normal, homogenized [OPG study]7.5342877
GSM549129patient 027, cancer, homogenized [OPG study]5.2459445
GSM549123patient 088, normal, homogenized [OPG study]6.7894369
GSM549124patient 006, cancer, homogenized [OPG study]5.0155940
GSM549126patient 015, cancer, homogenized [OPG study]5.0553141
GSM549128patient 025, cancer, homogenized [OPG study]7.1044672
GSM549103patient 117, normal, homogenized [OPG study]6.6009667
GSM549117patient 073, normal, homogenized [OPG study]5.130944
GSM549138patient 041, cancer, homogenized [OPG study]7.8401179
GSM549141patient 045, cancer, homogenized [OPG study]6.7265967
GSM549130patient 028, cancer, homogenized [OPG study]5.6667253
GSM549101patient 111, normal, homogenized [OPG study]10.120295
GSM549105patient 128, normal, homogenized [OPG study]6.3265763
GSM549106patient 134, normal, homogenized [OPG study]11.666598
GSM549112patient 048, normal, homogenized [OPG study]6.9404171
GSM549125patient 011, cancer, homogenized [OPG study]4.9977840
GSM549127patient 024, cancer, homogenized [OPG study]8.6683387
GSM549135patient 035, cancer, homogenized [OPG study]6.3025663